[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

MY109504A - Monohydrate of 5-(2-(4-(1,2 benzisothiazol-3-yl)-1- piperazinyl)-ethyl)-6-chloro-1,3-dihydro-2h-indol-2- one hydrochloride - Google Patents

Monohydrate of 5-(2-(4-(1,2 benzisothiazol-3-yl)-1- piperazinyl)-ethyl)-6-chloro-1,3-dihydro-2h-indol-2- one hydrochloride

Info

Publication number
MY109504A
MY109504A MYPI93001749A MYPI19931749A MY109504A MY 109504 A MY109504 A MY 109504A MY PI93001749 A MYPI93001749 A MY PI93001749A MY PI19931749 A MYPI19931749 A MY PI19931749A MY 109504 A MY109504 A MY 109504A
Authority
MY
Malaysia
Prior art keywords
benzisothiazol
indol
piperazinyl
monohydrate
dihydro
Prior art date
Application number
MYPI93001749A
Inventor
A Diroma Sabeto
M Godek Dennis
R Busch Frank
J M Allen Douglas
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of MY109504A publication Critical patent/MY109504A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

THE MONOHYDRATE OF 5-(2-(4-(1, 2- BENZISOTHIAZOL- 3- YL)- 1- PIPERAZINYL)ETHYL)- 6-CHLORO-1, 3-DIHYDRO-2H-INDOL-2-ONE HYDROCHLORIDE HAS ADVANTAGEOUS STABILITY FOR FORMULATION AS A NEUROLEPTIC AGENT.
MYPI93001749A 1992-09-01 1993-08-28 Monohydrate of 5-(2-(4-(1,2 benzisothiazol-3-yl)-1- piperazinyl)-ethyl)-6-chloro-1,3-dihydro-2h-indol-2- one hydrochloride MY109504A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US93420492A 1992-09-01 1992-09-01

Publications (1)

Publication Number Publication Date
MY109504A true MY109504A (en) 1997-02-28

Family

ID=80040646

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI93001749A MY109504A (en) 1992-09-01 1993-08-28 Monohydrate of 5-(2-(4-(1,2 benzisothiazol-3-yl)-1- piperazinyl)-ethyl)-6-chloro-1,3-dihydro-2h-indol-2- one hydrochloride

Country Status (1)

Country Link
MY (1) MY109504A (en)

Similar Documents

Publication Publication Date Title
CA2105114A1 (en) Monohydrate of 5-(2-(4-(1,2 Benzisothiazol-3-Yl)-1- Piperazinyl)-Ethyl)-6-Chloro-1,3-Dihydro-2H-Indol-2-One Hydrochloride
RU93043528A (en) 5- (2- (4- (1,2-BENZOTIAZOL-3-IL) -1-PIPERAZINYL) Ethyl MONOHYDRATE) -6-CHLOR-1,3-DIHYDRO-2H-INDOL-2-OH CHLOROHYDRATE, METHOD FOR ITS PREPARATION , PHARMACEUTICAL COMPOSITION, METHOD OF TREATMENT
TW427989B (en) Mesylate trihydrate of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)-ethyl)-6-chloro-1,3-dihydro-2H-indol-2-one
MY119997A (en) Mesylate dihydrate salts of 5-(2-(4-(1, 2-benzisothiazol-3-yl) -1-piperazinyl)-6-chloro-1, 3- dihydro-2h-indol-2-one
AP2001002066A0 (en) Substituted oxazoles and thiazoles derivatives at hPPAR gamma and hPPAR alpha activators
RS51343B (en) Novel composition and use
CA2396738A1 (en) Thiazole derivatives as active superoxide radical inhibitors
WO1999009025A3 (en) 2-(4-aryl or heteroaryl-piperazin-1-ylmethyl)-1h-indole derivatives interacting with the dopamine d4 receptor
JO2239B1 (en) Process for the preparation of benzothiophene derivatives
GB9718903D0 (en) Method,compositions and kits for increasing the oral bioavailability of pharmaceutical agents
NZ237309A (en) 1-(2-(4-morpholino)ethyl)-3-(arylcarbonyl)-indole derivatives and pharmaceutical compositions
MX9701116A (en) Pro-drugs of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)ethyl)-6-chl oro-1,3-dihydro-2h-indol-2-one.
EP0816362A4 (en) Thiazole derivatives
CY1107300T1 (en) Acrylic derivatives of 5- (2- (4- (1,2-benzisothiazol-3-yl) -1-piperazinyl) ethyl) -6-chloro-1,3-dihydro-2H-indol-2-one-hour
MY109504A (en) Monohydrate of 5-(2-(4-(1,2 benzisothiazol-3-yl)-1- piperazinyl)-ethyl)-6-chloro-1,3-dihydro-2h-indol-2- one hydrochloride
HU9202914D0 (en) 4-(4-(4-hydroxiphenyl)-1-piperazinyl)-5-methyl-3h-1,2,4-triazole-3-one derivatives
NO954892D0 (en) Heterocyclic chemistry
ES2083319A1 (en) 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)-ethyl)- 6 chloro-1,3-dihydro-2H-indole-2-one hydrochloride monohydrate
GB0021784D0 (en) Novel pharmaceutical
ES2156605T3 (en) PROCEDURE FOR PREPARATION OF A 3,5-DIHYDROCLORIDE HYDROCHLATE 3- (2- (4- (3-CHLORO-2-METHYLPHENYL) -1-PIPERAZINYL) ETHYL) -5,6-DIMETOXI-1- (4-IMIDAZOLILMETIL ) -1H-INDAZOL.
ES2062940A1 (en) Gastrokinetic agent, process for its preparation and pharmaceutical compositions containing said agent
ECSP972089A (en) SALT MESYLATE TRIHYDRATE 5- [2- [4 (1,2-BENZOISOTIAZOL-3-IL] -1-PIPERAZINYL) ETHYL] -6-CHLORINE- 1,3- DIHYDRO- 2H- INDDOL - 2 - ONA
HUP9902404A2 (en) Mesylate dihydrate salts of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)-ethyl)-6-choloro-1,3-dihydro-2(2h)-indol-2-one (-ziprasidone), its preparation and its use as dopamine d2 antagonist
RU2001135856A (en) Compounds VLA-4 Inhibitors
MY110446A (en) Piperazine derivatives